Predifferentiated adult stem cells and matrices for cardiac cell therapy

Asian Cardiovascular and Thoracic Annals

Volumn 18, Issue 1, 2010, Pages 79-87

  Spadaccio, Cristiano ^a   Chachques, Emmanuel ^b   Chello, Massimo ^a   Covino, Elvio ^a   Chachques, Juan C ^c   Genovese, Jorge ^a  

^a UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^b SORBONNE UNIVERSITÉ   (France)

^c HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

Adult stem cells; Cell transplantation; Heart failure; Infarction; Myocardial; Tissue engineering

Indexed keywords

BIOMATERIAL; COLLAGEN; CONNEXIN 43; CYTOKINE; DESMIN; FIBRIN; FOLLISTATIN; GROWTH FACTOR; HYALURONIC ACID; TROPONIN;

ADIPOCYTE DERIVED STEM CELL; ADULT STEM CELL; CARDIOMYOPATHY; CELL DIFFERENTIATION; CELL FUNCTION; CELL HOMING; CELL PROLIFERATION; CELL SURVIVAL; CELL TRANSFORMATION; CELL TYPE; CLINICAL TRIAL; DRUG DELIVERY SYSTEM; ELECTROSTIMULATION; EMBRYONIC STEM CELL; EXTRACELLULAR MATRIX; HEART FAILURE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE STEM CELL; HEART VENTRICLE REMODELING; HEMATOPOIETIC STEM CELL; HUMAN; MESENCHYMAL STEM CELL; MUSCLE STEM CELL; NONHUMAN; PHENOTYPE; PLURIPOTENT STEM CELL; REVIEW; STEM CELL; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING; TISSUE REPAIR; HEART DISEASE; METHODOLOGY;

ADULT STEM CELLS; CELL DIFFERENTIATION; HEART DISEASES; HUMANS; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING;

EID: 77449093126     PISSN: 02184923     EISSN: None     Source Type: Journal    
DOI: 10.1177/0218492309355836     Document Type: Review

References (62)

1. Li L, Zhang S, Zhang Y, Yu B, Xu Y, Guan Z. Paracrine action mediate the antifibrotic effect of transplanted mesenchymal stem cells in a rat model of global heart failure. Mol Biol Rep 2009;36:725-731
2. Dai W, Hale SL, Kloner RA. Role of a paracrine action of mesenchymal stem cells in the improvement of left ventricular function after coronary artery occlusion in rats. Regen Med 2007;2:63-68
3. Genovese JA, Spadaccio C, Chachques E, Schussler O, Carpentier A, Chachques JC, et al. Cardiac pre-differentiation of human mesenchymal stem cells by electrostimulation. Front Biosci 2009;14:2996-3002.
4. Genovese JA, Spadaccio C, Langer J, Habe J, Jackson J, Patel AN. Electrostimulation induces cardiomyocyte predifferentiation of fibroblasts. Biochem Biophys Res Commun 2008;370:450-455
5. Leri A, Hosoda T, Kajstura J, Anversa P. Heart failure and regenerative cardiology. Regen Med 2006;1:153-159
6. Stamm C, Liebold A, Steinhoff G, Strunk D. Stem cell therapy for ischemic heart disease: beginning or end of the road? Cell Transplant 2006;15(Suppl 1)S47-56.
7. Segers VF, Lee RT. Stem-cell therapy for cardiac disease [Review]. Nature 2008;451(7181):937-942
8. Chachques JC, Herreros J, Trainini J, Juffe A, Rendal E, Prosper F, et al. Autologous human serum for cell culture avoids the implantation of cardioverter-defibrillators in cellular cardiomyoplasty. Int J Cardiol 2004;95(Suppl 1):S29-33.
9. Caplan AI, Dennis JE. Mesenchymal stem cells as trophic mediators [Review]. J Cell Biochem 2006;98:1076-1084
10. Wollert KC, Drexler H. Clinical applications of stem cells for the heart [Review]. Circ Res 2005;96:151-163
11. Psaltis PJ, Zannettino AC, Worthley SG, Gronthos S. Concise review: mesenchymal stromal cells: potential for cardiovascular repair. Stem Cells 2008;26:2201-2210
12. Strem BM, Zhu M, Alfonso Z, Daniels EJ, Schreiber R, Beygui R, et al. Expression of cardiomyocytic markers on adipose tissue-derived cells in a murine model of acute myocardial injury. Cytotherapy 2005;7:282-291
13. Winitsky SO, Gopal TV, Hassanzadeh S, Takahashi H, Gryder D, Rogawski MA, et al. Adult murine skeletal muscle contains cells that can differentiate into beating cardiomyocytes in vitro. PLoS Biol 2005;3:e87.
14. Beltrami AP, Barlucchi L, Torella D, Baker M, Limana F, Chimenti S, et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 2003;114:763-776
15. Oh H, Chi X, Bradfute SB, Mishina Y, Pocius J, Michael LH, et al. Cardiac muscle plasticity in adult and embryo by heart-derived progenitor cells. Ann N Y Acad Sci 2004;1015:182-189
16. Byrne JA, Pedersen DA, Clepper LL, Nelson M, Sanger WG, Gokhale S, et al. Producing primate embryonic stem cells by somatic cell nuclear transfer. Nature 2007;450(7169):497-502.
17. Mitalipov SM, Zhou Q, Byrne JA, Ji WZ, Norgren RB, Wolf DP. Reprogramming following somatic cell nuclear transfer in primates is dependent upon nuclear remodeling. Hum Reprod 2007;22:2232-2242
18. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007;131:861-872
19. Mazhari R, Hare JM. Advances in cell-based therapy for structural heart disease [Review]. Prog Cardiovasc Dis 2007;49:387-395
20. Menasché P, Hagège AA, Vilquin JT, Desnos M, Abergel E, Pouzet B, et al. Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J Am Coll Cardiol 2003;41:1078-1083
21. Cleland JG, Freemantle N, Coletta AP, Clark AL. Clinical trials update from the American Heart Association: REPAIR-AMI, ASTAMI, JELIS, MEGA, REVIVE-II, SURVIVE, and PROACTIVE [Review]. Eur J Heart Fail 2006;8:105-110
22. Tousoulis D, Briasoulis A, Antoniades C, Stefanadi E, Stefanadis C. Heart regeneration: what cells to use and how? Curr Opin Pharmacol 2008;8:211-218
23. Chen SL, Fang WW, Ye F, Liu YH, Qian J, Shan SJ, et al. Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am J Cardiol 2004;94:92-95 (Pubitemid 38813459)
24. Lunde K, Solheim S, Aakhus S, Arnesen H, Abdelnoor M, Forfang K. Autologous stem cell transplantation in acute myocardial infarction: The ASTAMI randomized controlled trial. Intracoronary transplantation of autologous mononuclear bone marrow cells, study design and safety aspects. Scand Cardiovasc J 2005;39:150-158
25. Lunde K, Solheim S, Aakhus S, Arnesen H, Abdelnoor M, Egeland T, et al. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med 2006;355:1199-1209
26. Cogle CR, Madlambayan GJ, Hubsher G, Beckman C, Speisman R, Tran-Son-Tay R, et al. Marrow cell therapies for cardiovascular diseases. Exp Hematol 2008;36:687-694
27. Tse HF, Kwong YL, Chan JK, Lo G, Ho CL, Lau CP. Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation. Lancet 2003;361(9351):47-49
28. Thompson CA, Nasseri BA, Makower J, Houser S, McGarry M, Lamson T, et al. Percutaneous transvenous cellular cardiomyoplasty. A novel nonsurgical approach for myocardial cell transplantation. J Am Coll Cardiol 2003;41:1964-1971
29. Perin EC, Dohmann HF, Borojevic R, Silva SA, Sousa AL, Silva GV, et al. Improved exercise capacity and ischemia 6 and 12 months after transendocardial injection of autologous bone marrow mononuclear cells for ischemic cardiomyopathy. Circulation 2004;110(Suppl I):213-218
30. Kawahara Y, Yamaoka K, Iwata M, Fujimura M, Kajiume T, Magaki T, et al. Novel electrical stimulation sets the cultured myoblast contractile function to 'on'. Pathobiology 2006;73:288-294
31. Yuge L, Kataoka K. Differentiation of myoblasts is accelerated in culture in a magnetic field. In Vitro Cell Dev Biol Anim 2000;36:383-386
32. Genovese JA, Spadaccio C, Rivello HG, Toyoda Y, Patel AN. Electrostimulated bone marrow human mesenchymal stem cells produce follistatin. Cytotherapy 2009;11:448-456
33. Cortes-Morichetti M, Frati G, Schussler O, Van Huyen JP, Lauret E, Genovese JA, et al. Association between a cell-seeded collagen matrix and cellular cardiomyoplasty for myocardial support and regeneration. Tissue Eng 2007;13:2681-2687
34. Spadaccio C, Chello M, Trombetta M, Rainer A, Toyoda Y, Genovese J. Drug releasing systems in cardiovascular tissue engineering. J Cell Mol Med 2009;13(3):422-439
35. Christman KL, Fok HH, Sievers RE, Fang Q, Lee RJ. Fibrin glue alone and skeletal myoblasts in a fibrin scaffold preserve cardiac function after myocardial infarction. Tissue Eng 2004;10:403-409
36. Ryu JH, Kim IK, Cho SW, Cho MC, Hwang KK, Piao H, et al. Implantation of bone marrow mononuclear cells using injectable fibrin matrix enhances neovascularization in infarcted myocardium. Biomaterials 2005;26:319-326
37. Chekanov VS, Nikolaychik V, Maternowski MA, Mehran R, Leon MB, Adamian M, et al. Deferoxamine enhances neovascularization and recovery of ischemic skeletal muscle in an experimental sheep model. Ann Thorac Surg 2003;75:184-189
38. Zimmermann WH, Melnychenko I, Wasmeier G, Didie M, Naito H, Nixdorff U, et al. Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts. Nat Med 2006;12:452-458
39. Kofidis T, de Bruin JL, Hoyt G, Ho Y, Tanaka M, Yamane T, et al. Myocardial restoration with embryonic stem cell bioartificial tissue transplantation. J Heart Lung Transplant 2005;24:737-744
40. Kofidis T, de Bruin JL, Hoyt G, Lebl DR, Tanaka M, Yamane T, et al. Injectable bioartificial myocardial tissue for large-scale intramural cell transfer and functional recovery of injured heart muscle. J Thorac Cardiovasc Surg 2004;128:571-578
41. Kofidis T, Lebl DR, Martinez EC, Hoyt G, Tanaka M, Robbins RC. Novel injectable bioartificial tissue facilitates targeted, less invasive, large-scale tissue restoration on the beating heart after myocardial injury. Circulation 2005;112(Suppl I):173-177
42. Zhang P, Zhang H, Wang H, Wei Y, Hu S. Artificial matrix helps neonatal cardiomyocytes restore injured myocardium in rats. Artif Organs 2006;30:86-93.
43. Zimmermann WH, Didie M, Wasmeier GH, Nixdorff U, Hess A, Melnychenko I, et al. Cardiac grafting of engineered heart tissue in syngenic rats. Circulation 2002;106(Suppl I):151-157
44. Leor J, Aboulafia-Etzion S, Dar A, Shapiro L, Barbash IM, Battler A, et al. Bioengineered cardiac grafts: A new approach to repair the infarcted myocardium? Circulation 2000;102(Suppl II)156-161
45. Kellar RS, Shepherd BR, Larson DF, Naughton GK, Williams SK. Cardiac patch constructed from human fibroblasts attenuates reduction in cardiac function after acute infarct. Tissue Eng 2005;11:1678-1687
46. Krupnick AS, Kreisel D, Engels FH, Szeto WY, Plappert T, Popma SH, et al. A novel small animal model of left ventricular tissue engineering. J Heart Lung Transplant 2002;21:233-243
47. Siepe M, Giraud MN, Pavlovic M, Receputo C, Beyersdorf F, Menasché P, et al. Myoblast-seeded biodegradable scaffolds to prevent post-myocardial infarction evolution toward heart failure. J Thorac Cardiovasc Surg 2006;132:124-131
48. Miyahara Y, Nagaya N, Kataoka M, Yanagawa B, Tanaka K, Hao H, et al. Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. Nat Med 2006;12:459-465
49. Davis ME, Motion JP, Narmoneva DA, Takahashi T, Hakuno D, Kamm RD, et al. Injectable self-assembling peptide nanofibers create intramyocardial microenvironments for endothelial cells. Circulation 2005;111:442-450
50. Dubois G, Segers VF, Bellamy V, Sabbah L, Peyrard S, Bruneval P, et al. Self-assembling peptide nanofibers and skeletal myoblast transplantation in infarcted myocardium. J Biomed Mater Res B Appl Biomater 2008;87:222-228
51. Matsubayashi K, Fedak PW, Mickle DA, Weisel RD, Ozawa T, Li RK. Improved left ventricular aneurysm repair with bioengineered vascular smooth muscle grafts. Circulation 2003;108(Suppl I):219-225
52. Remuzzi A, Mantero S, Colombo M, Morigi M, Binda E, Camozzi D, et al. Vascular smooth muscle cells on hyaluronic acid: culture and mechanical characterization of an engineered vascular construct. Tissue Eng 2004;10:699-710.
53. Schaner PJ, Martin ND, Tulenko TN, Shapiro IM, Tarola NA, Leichter RF, et al. Decellularized vein as a potential scaffold for vascular tissue engineering. J Vasc Surg 2004;40:146-153
54. Chachques JC, Trainini JC, Lago N, Masoli OH, Barisani JL, Cortes-Morichetti M, et al. Myocardial assistance by grafting a new bioartificial upgraded myocardium (MAGNUM clinical trial): one year follow-up. Cell Transplant 2007;16:927-934
55. Chachques JC, Trainini JC, Lago N, Cortes-Morichetti M, Schussler O, Carpentier A. Myocardial Assistance by Grafting a New Bioartificial Upgraded Myocardium (MAGNUM trial): clinical feasibility study. Ann Thorac Surg 2008;85:901-908
56. Xu C, Inai R, Kotaki M, Ramakrishna S. Electrospun nanofiber fabrication as synthetic extracellular matrix and its potential for vascular tissue engineering. Tissue Eng 2004;10:1160-1168
57. Spadaccio C, Rainer A, Trombetta M, Vadala G, Chello M, Covino E, et al. Poly-L-lactic acid/hydroxyapatite electrospun nanocomposites induce chondrogenic differentiation of human MSC. Ann Biomed Eng 2009;37:1376-1389
58. Spadaccio C, Rainer A, Chello M, Covino E, Trombetta M, Genovese J. Drug releasing hybrid scaffold: new avenue in cardiovascular tissue engineering. Tissue Eng Part A 2008;14:691-943.
59. Davis ME, Hsieh PC, Takahashi T, Song Q, Zhang S, Kamm RD, et al. Local myocardial insulin-like growth factor 1 (IGF-1) delivery with biotinylated peptide nanofibers improves cell therapy for myocardial infarction. Proc Natl Acad Sci U S A 2006;103:8155-8160
60. Ishii O, Shin M, Sueda T, Vacanti JP. In vitro tissue engineering of a cardiac graft using a degradable scaffold with an extracellular matrix-like topography. J Thorac Cardiovasc Surg 2005;130:1358-1363
61. Stankus JJ, Guan J, Wagner WR. Fabrication of biodegradable elastomeric scaffolds with sub-micron morphologies. J Biomed Mater Res A 2004;70:603-614
62. Piao H, Kwon JS, Piao S, Sohn JH, Lee YS, Bae JW, et al. Effects of cardiac patches engineered with bone marrow-derived mononuclear cells and PGCL scaffolds in a rat myocardial infarction model. Biomaterials 2007;28:641-649